Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1997 1
2000 1
2001 1
2002 1
2003 2
2004 4
2005 5
2006 9
2007 8
2008 4
2009 4
2010 3
2011 4
2012 8
2013 1
2014 5
2015 6
2016 6
2017 5
2018 3
2019 6
2020 4
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 22218624

81 results
Results by year
Filters applied: . Clear all
Page 1
Proton pump inhibitor therapy associated with lower glycosylated hemoglobin levels in type 2 diabetes.
Crouch MA, Mefford IN, Wade EU. Crouch MA, et al. J Am Board Fam Med. 2012 Jan-Feb;25(1):50-4. doi: 10.3122/jabfm.2012.01.100161. J Am Board Fam Med. 2012. PMID: 22218624 Free article.
The effect of proton pump inhibitors on glycated hemoglobin levels in patients with type 2 diabetes mellitus.
Han N, Oh M, Park SM, Kim YJ, Lee EJ, Kim TK, Kim TN, Kwon MJ, Kim MK, Lee SH, Rhee BD, Park JH. Han N, et al. Can J Diabetes. 2015 Feb;39(1):24-8. doi: 10.1016/j.jcjd.2013.10.008. Epub 2014 Oct 8. Can J Diabetes. 2015. PMID: 25305802
Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
Robbins DC, Beisswenger PJ, Ceriello A, Goldberg RB, Moses RG, Pagkalos EM, Milicevic Z, Jones CA, Sarwat S, Tan MH. Robbins DC, et al. Clin Ther. 2007 Nov;29(11):2349-64. doi: 10.1016/j.clinthera.2007.11.016. Clin Ther. 2007. PMID: 18158076 Clinical Trial.
Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study.
Yurgin N, Secnik K, Lage MJ. Yurgin N, et al. Clin Ther. 2007 Feb;29(2):316-25. doi: 10.1016/j.clinthera.2007.02.012. Clin Ther. 2007. PMID: 17472823
Fixed-dose combination antidiabetic therapy: real-world factors associated with prescribing choices and relationship with patient satisfaction and compliance.
Benford M, Milligan G, Pike J, Anderson P, Piercy J, Fermer S. Benford M, et al. Adv Ther. 2012 Jan;29(1):26-40. doi: 10.1007/s12325-011-0096-z. Epub 2012 Jan 12. Adv Ther. 2012. PMID: 22246944
Comparison of insulin lispro mixture 25/75 with insulin glargine during a 24-h standardized test-meal period in patients with Type 2 diabetes.
Roach P, Malone JK. Roach P, et al. Diabet Med. 2006 Jul;23(7):743-9. doi: 10.1111/j.1464-5491.2006.01895.x. Diabet Med. 2006. PMID: 16842478 Clinical Trial.
Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial.
Derosa G, Cicero AF, Gaddi AV, Ciccarelli L, Piccinni MN, Salvadeo S, Pricolo F, Fogari E, Ghelfi M, Ferrari I, Fogari R. Derosa G, et al. Clin Ther. 2005 Sep;27(9):1383-91. doi: 10.1016/j.clinthera.2005.09.003. Clin Ther. 2005. PMID: 16291411 Clinical Trial.
A treatment strategy implementing combination therapy with sitagliptin and metformin results in superior glycaemic control versus metformin monotherapy due to a low rate of addition of antihyperglycaemic agents.
Olansky L, Reasner C, Seck TL, Williams-Herman DE, Chen M, Terranella L, Mehta A, Kaufman KD, Goldstein BJ. Olansky L, et al. Diabetes Obes Metab. 2011 Sep;13(9):841-9. doi: 10.1111/j.1463-1326.2011.01416.x. Diabetes Obes Metab. 2011. PMID: 21535346 Clinical Trial.
Evidence of a threshold value of glycated hemoglobin to improve the course of renal function in type 2 diabetes with typical diabetic glomerulopathy.
Brocco E, Velussi M, Cernigoi AM, Abaterusso C, Bruseghin M, Carraro A, Sambataro M, Piarulli F, Sfriso A, Nosadini R. Brocco E, et al. J Nephrol. 2001 Nov-Dec;14(6):461-71. J Nephrol. 2001. PMID: 11783602 Clinical Trial.
Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial.
Jadzinsky M, Pfützner A, Paz-Pacheco E, Xu Z, Allen E, Chen R; CV181-039 Investigators. Jadzinsky M, et al. Diabetes Obes Metab. 2009 Jun;11(6):611-22. doi: 10.1111/j.1463-1326.2009.01056.x. Diabetes Obes Metab. 2009. PMID: 19515181 Clinical Trial.
81 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback